Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter
Research Paper

White matter network alterations in patients with depersonalization/derealization disorder

Anika Sierk, Judith K. Daniels, Antje Manthey, Jelmer G. Kok, Alexander Leemans, Michael Gaebler, Jan-Peter Lamke, Johann Kruschwitz and Henrik Walter
J Psychiatry Neurosci September 01, 2018 43 (5) 347-357; DOI: https://doi.org/10.1503/jpn.170110
Anika Sierk
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith K. Daniels
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antje Manthey
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jelmer G. Kok
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Leemans
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Gaebler
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan-Peter Lamke
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johann Kruschwitz
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Walter
From the Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany (Sierk, Manthey, Lamke, Kruschwitz, Walter); the Institute of Cognitive Neuroscience, University College London, London, UK (Sierk); the Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands (Daniels); the Department of Neurology, University of Groningen, University Medical Center Groningen, The Netherlands (Kok); the PROVIDI Lab, University Medical Center Utrecht, Utrecht, the Netherlands (Leemans); and the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (Gaebler)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Fig. 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1

    Flowchart of the preprocessing pipeline using FreeSurfer (https://surfer.nmr.mgh.harvard.edu) and ExploreDTI (www.exploredti.com). CSD = constrained spherical deconvolution; EPI = echo-planar imaging.

  • Fig. 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2

    Visualization of the trend found in the group comparison when using network-based statistics. At an initial-link threshold of plt = 0.005, a subnetwork was identified for which patients with depersonalization/derealization disorder (DPD) displayed lower fractional anisotropy (FA) (blue edges) as well as higher FA (red edges) than healthy controls (pFWE = 0.08). Patients showed relatively lower FA values between the left caudate, brainstem and the right amygdala, and higher FA between the left superior frontal gyrus, right medial frontal cortex and the right amygdala. FWE = family-wise error.

  • Fig. 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3

    Visualization of the 2 most outstanding results of the group comparison when using a link-based controlling procedure. First, (A) patients with depersonalization/derealization disorder (DPD) showed significantly lower fractional anisotropy (FA) between the right middle temporal gyrus and the right supramarginal gyrus. (B) The FA values within this connection were negatively correlated with dissociative symptom scores across groups, as measured by the CDS-30. Second, (C) relative to controls, patients with DPD showed significantly lower FA values between the left temporal pole and the left superior temporal gyrus. (D) Dissociative symptom severity correlated negatively with FA values of this connection. CDS = Cambridge Depersonalization Scale; FDR = false discovery rate; MTG = middle temporal gyrus; SMG = supramarginal gyrus; STG = superior temporal gyrus.

Tables

  • Figures
    • View popup
    Table 1

    Demographic characteristics and clinical measures

    DPDControl
    CharacteristicnMean ± SDnMean ± SD2-tailed t testp value
    Age, yr2330.61 ± 7.312329.96 ± 7.99t44 = 0.2890.774
    Handedness230.76 ± 0.50230.92 ± 0.15t44 = −1.5420.135
    CDS-3022148.14 ± 43.10239.61 ± 12.04t43 = 14.543< 0.001
    CDS-State23926.96 ± 383.5222173.64 ± 254.40t43 = 7.796< 0.001
    DES22442.27 ± 217.952336.09 ± 39.05t43 = 8.610< 0.001
    BDI-II2220.32 ± 11.27232.48 ± 3.41t43 = 7.120< 0.001
    STAI-T2256.23 ± 11.802334.00 ± 11.37t43 = 6.434< 0.001
    LSAS22442.27 ± 217.952336.09 ± 39.05t43 = 3.7380.001
    TAS-202255.59 ± 8.662352.00 ± 7.07t43 = 5.785< 0.001
    ERQ2242.68 ± 8.982339.52 ± 9.62t43 = 1.1380.262
    KIMS2286.68 ± 19.7123124.39 ± 13.43t43 = −7.531< 0.001
    DFS2270.36 ± 9.522361.65 ± 9.24t43 = 3.1190.003
    CTQ_sum2252.32 ± 17.522344.22 ± 10.33t43 = 1.8780.069
    CTQ_PA226.36 ± 2.68235.91 ± 1.91t43 = 0.6520.518
    CTQ_PN225.50 ± 2.76234.00 ± 1.54t43 = 2.2410.032
    CTQ_EA2211.00 ± 4.04235.91 ± 1.91t43 = 1.7650.086
    CTQ_EN226.91 ± 5.86234.57 ± 5.27t43 = 1.4110.165
    CTQ_SA226.45 ± 2.30235.65 ± 1.72t43 = 1.1190.269
    TMT-A2124.62 ± 5.522124.90 ± 6.80t40 = −0.1500.882
    TMT-B2151.38 ± 14.202153.19 ± 18.59t40 = −0.3550.725
    • BDI = Beck Depression Inventory; CDS = Cambridge Depersonalization Scale; CTQ = Childhood Trauma Questionnaire; DES = Dissociative Experiences Scale; DFS = Questionnaire for functional and dysfunctional self-focused attention; DPD = depersonalization/derealization disorder; EA = emotional abuse; EN = emotional neglect; ERQ = Emotion Regulation Questionnaire; KIMS = Kentucky Inventory of Mindfulness Skills; LSAS = Liebowitz Social Anxiety Scale; PA = physical abuse; PN = physical neglect; SA = sexual abuse; SD = standard deviation; STAI-T = State-Trait Anxiety Scale, trait version; TAS = Toronto Alexithymia Scale, TMT = Trail Making Test.

    • View popup
    Table 2

    Current and lifetime comorbid disorders in patients with DPD (n = 23)

    DisorderCurrent, nLifetime, n
    Anxiety disorders1111
     Social anxiety disorder
     Panic disorder23
     Specific phobia22
     Obsessive–compulsive disorder22
     Generalized anxiety disorder11
    Mood disorders210
     Major depressive disorder
    Personality disorders11
     Emotionally unstable – impulsive type
     Emotionally unstable – borderline type11
     Anxious avoidant11
     Dependent11
    Other01
     Posttraumatic stress disorder
     Conversion disorder01
     Impulse control disorder11
     Eating disorder03
     Substance abuse disorder01
    Total comorbidity1719
    • DPD = depersonalization/derealization disorder.

    • View popup
    Table 3

    Group comparison using link-based controlling procedure, controlled for age, sex and handedness*

    Negative correlation between symptom scores and FA values
    BDISTAI-TCDSSignificant components DPD ≠ HC†pFDR value
    ——✓Left temporal pole − − Left superior temporal gyrus< 0.001
    ——✓Right middle temporal gyrus − − Right supramarginal gyrus0.002
    —✓✓Brain stem − − Left caudate< 0.001
    ✓✓✓Right medial OFC − − Right caudal ACC0.001
    —✓—Right inferior temporal gyrus − − Right lingual cortex< 0.001
    ———Right superior temporal gyrus + + Right banks of superior temporal sulcus< 0.01
    ———Left insula − − Left pars triangularis − − Left lateral OFC< 0.01
    ———Left caudal ACC − − Left medial OFC + + Right superior frontal gyrus< 0.01
    ———Left isthmus of the cingulate cortex + + Right cuneus + + Left superior parietal cortex< 0.01
    • ACC = anterior cingulate cortex; BDI = Beck Depression Inventory; CDS = Cambridge Depersonalization Scale; DPD = depersonalization/derealization disorder; FA = fractional anisotropy; FDR = false discovery rate; HC = healthy controls; STAI-T = State-Trait Anxiety Scale, trait version; OFC = orbitofrontal cortex.

    • ↵* All components for which patients with DPD and controls displayed significantly different FA values are listed along with the respective p value. Ticks mark components for which a significant correlation was found with dissociative symptoms scores (CDS-30), trait anxiety (STAI-T), or depression (BDI).

    • ↵† Minus signs between brain regions (− −) represent connections for which patients with DPD displayed lower FA values than controls; plus signs between regions (+ +) represent connections for which patients displayed higher FA values than controls.

PreviousNext
Back to top

In this issue

Journal of Psychiatry and Neuroscience: 43 (5)
J Psychiatry Neurosci
Vol. 43, Issue 5
1 Sep 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on JPN.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
White matter network alterations in patients with depersonalization/derealization disorder
(Your Name) has sent you a message from JPN
(Your Name) thought you would like to see the JPN web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
White matter network alterations in patients with depersonalization/derealization disorder
Anika Sierk, Judith K. Daniels, Antje Manthey, Jelmer G. Kok, Alexander Leemans, Michael Gaebler, Jan-Peter Lamke, Johann Kruschwitz, Henrik Walter
J Psychiatry Neurosci Sep 2018, 43 (5) 347-357; DOI: 10.1503/jpn.170110

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
White matter network alterations in patients with depersonalization/derealization disorder
Anika Sierk, Judith K. Daniels, Antje Manthey, Jelmer G. Kok, Alexander Leemans, Michael Gaebler, Jan-Peter Lamke, Johann Kruschwitz, Henrik Walter
J Psychiatry Neurosci Sep 2018, 43 (5) 347-357; DOI: 10.1503/jpn.170110
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire